This article focuses on the recent immunotherapy updates to the treatment of renal cell carcinoma (RCC) as given in the RCC: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

Porta C.;
2021-01-01

Abstract

This article focuses on the recent immunotherapy updates to the treatment of renal cell carcinoma (RCC) as given in the RCC: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
File in questo prodotto:
File Dimensione Formato  
ESMO-Clinical-Practice-Guideline-update-on-the-use-of-immunot_2021_Annals-of.pdf

accesso aperto

Descrizione: Article
Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 386.24 kB
Formato Adobe PDF
386.24 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/393177
Citazioni
  • ???jsp.display-item.citation.pmc??? 78
  • Scopus 150
  • ???jsp.display-item.citation.isi??? 145
social impact